Sign up to save your podcasts
Or
Share 302: Vertex's big deal, biotech's red numbers, & an industry history lesson
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
302: Vertex's big deal, biotech's red numbers, & an industry history lesson
How would you spend $13 billion in cash? Is biotech stale? And remember Dendreon?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss a multibillion-dollar deal from Vertex Pharmaceuticals with sweeping implications and a lengthy backstory. We also explain why gas prices are weighing on biotech, and make a surprise announcement.
View all episodes
By STAT
4.5
304304 ratings
How would you spend $13 billion in cash? Is biotech stale? And remember Dendreon?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss a multibillion-dollar deal from Vertex Pharmaceuticals with sweeping implications and a lengthy backstory. We also explain why gas prices are weighing on biotech, and make a surprise announcement.
More shows like The Readout Loud
View all
Planet Money
30,845 Listeners
a16z Podcast
1,040 Listeners
Odd Lots
1,789 Listeners
KFF Health News' 'What the Health?'
478 Listeners
The Long Run with Luke Timmerman
122 Listeners
Talks at GS
84 Listeners
The Journal.
5,942 Listeners
Tradeoffs
391 Listeners
Biotech 2050 Podcast
59 Listeners
BioCentury This Week
29 Listeners
Hard Fork
5,462 Listeners
Raising Health
147 Listeners
Biotech Hangout
18 Listeners
Ground Truths
51 Listeners
Money Stuff: The Podcast
371 Listeners